000856622 001__ 856622
000856622 005__ 20210129235334.0
000856622 0247_ $$2doi$$a10.3389/fphys.2018.01490
000856622 0247_ $$2Handle$$a2128/19849
000856622 0247_ $$2WOS$$aWOS:000448008900001
000856622 0247_ $$2altmetric$$aaltmetric:50388205
000856622 0247_ $$2pmid$$apmid:30405442
000856622 037__ $$aFZJ-2018-05989
000856622 082__ $$a610
000856622 1001_ $$0P:(DE-HGF)0$$aWojciechowski, Daniel$$b0
000856622 245__ $$aBarttin Regulates the Subcellular Localization and Posttranslational Modification of Human Cl-/H+ Antiporter ClC-5
000856622 260__ $$aLausanne$$bFrontiers Research Foundation$$c2018
000856622 3367_ $$2DRIVER$$aarticle
000856622 3367_ $$2DataCite$$aOutput Types/Journal article
000856622 3367_ $$0PUB:(DE-HGF)16$$2PUB:(DE-HGF)$$aJournal Article$$bjournal$$mjournal$$s1540304418_27419
000856622 3367_ $$2BibTeX$$aARTICLE
000856622 3367_ $$2ORCID$$aJOURNAL_ARTICLE
000856622 3367_ $$00$$2EndNote$$aJournal Article
000856622 520__ $$aDent disease 1 (DD1) is a renal salt-wasting tubulopathy associated with mutations in the Cl-/H+ antiporter ClC-5. The disease typically manifests with proteinuria, hypercalciuria, nephrocalcinosis, and nephrolithiasis but is characterized by large phenotypic variability of no clear origin. Several DD1 cases have been reported lately with additional atypical hypokalemic metabolic alkalosis and hyperaldosteronism, symptoms usually associated with another renal disease termed Bartter syndrome (BS). Expression of the Bartter-like DD1 mutant ClC-5 G261E in HEK293T cells showed that it is retained in the ER and lacks the complex glycosylation typical for ClC-5 WT. Accordingly, the mutant abolished CLC ionic transport. Such phenotype is not unusual and is often observed also in DD1 ClC-5 mutants not associated with Bartter like phenotype. We noticed, therefore, that one type of BS is associated with mutations in the protein barttin that serves as an accessory subunit regulating the function and subcellular localization of ClC-K channels. The overlapping symptomatology of DD1 and BS, together with the homology between the proteins of the CLC family, led us to investigate whether barttin might also regulate ClC-5 transport. In HEK293T cells, we found that barttin cotransfection impairs the complex glycosylation and arrests ClC-5 in the endoplasmic reticulum. As barttin and ClC-5 are both expressed in the thin and thick ascending limbs of the Henle’s loop and the collecting duct, interactions between the two proteins could potentially contribute to the phenotypic variability of DD1. Pathologic barttin mutants differentially regulated trafficking and processing of ClC-5, suggesting that the interaction between the two proteins might be relevant also for the pathophysiology of BS. Our findings show that barttin regulates the subcellular localization not only of kidney ClC-K channels but also of the ClC-5 transporter, and suggest that ClC-5 might potentially play a role not only in kidney proximal tubules but also in tubular kidney segments expressing barttin. In addition, they demonstrate that the spectrum of clinical, genetic and molecular pathophysiology investigation of DD1 should be extended.
000856622 536__ $$0G:(DE-HGF)POF3-551$$a551 - Functional Macromolecules and Complexes (POF3-551)$$cPOF3-551$$fPOF III$$x0
000856622 588__ $$aDataset connected to CrossRef
000856622 7001_ $$0P:(DE-HGF)0$$aKovalchuk, Elena$$b1
000856622 7001_ $$0P:(DE-HGF)0$$aYu, Lan$$b2
000856622 7001_ $$0P:(DE-Juel1)164255$$aTan, Hua$$b3
000856622 7001_ $$0P:(DE-Juel1)136837$$aFahlke, Christoph$$b4$$ufzj
000856622 7001_ $$0P:(DE-Juel1)156347$$aStölting, Gabriel$$b5$$ufzj
000856622 7001_ $$0P:(DE-HGF)0$$aAlekov, Alexi K.$$b6$$eCorresponding author
000856622 773__ $$0PERI:(DE-600)2564217-0$$a10.3389/fphys.2018.01490$$gVol. 9, p. 1490$$p1490$$tFrontiers in physiology$$v9$$x1664-042X$$y2018
000856622 8564_ $$uhttps://juser.fz-juelich.de/record/856622/files/fphys-09-01490.pdf$$yOpenAccess
000856622 8564_ $$uhttps://juser.fz-juelich.de/record/856622/files/fphys-09-01490.pdf?subformat=pdfa$$xpdfa$$yOpenAccess
000856622 909CO $$ooai:juser.fz-juelich.de:856622$$pdnbdelivery$$pdriver$$pVDB$$popen_access$$popenaire
000856622 9101_ $$0I:(DE-588b)5008462-8$$6P:(DE-Juel1)136837$$aForschungszentrum Jülich$$b4$$kFZJ
000856622 9101_ $$0I:(DE-588b)5008462-8$$6P:(DE-Juel1)156347$$aForschungszentrum Jülich$$b5$$kFZJ
000856622 9131_ $$0G:(DE-HGF)POF3-551$$1G:(DE-HGF)POF3-550$$2G:(DE-HGF)POF3-500$$3G:(DE-HGF)POF3$$4G:(DE-HGF)POF$$aDE-HGF$$bKey Technologies$$lBioSoft – Fundamentals for future Technologies in the fields of Soft Matter and Life Sciences$$vFunctional Macromolecules and Complexes$$x0
000856622 9141_ $$y2018
000856622 915__ $$0StatID:(DE-HGF)0200$$2StatID$$aDBCoverage$$bSCOPUS
000856622 915__ $$0StatID:(DE-HGF)1050$$2StatID$$aDBCoverage$$bBIOSIS Previews
000856622 915__ $$0LIC:(DE-HGF)CCBY4$$2HGFVOC$$aCreative Commons Attribution CC BY 4.0
000856622 915__ $$0StatID:(DE-HGF)0100$$2StatID$$aJCR$$bFRONT PHYSIOL : 2017
000856622 915__ $$0StatID:(DE-HGF)0501$$2StatID$$aDBCoverage$$bDOAJ Seal
000856622 915__ $$0StatID:(DE-HGF)0500$$2StatID$$aDBCoverage$$bDOAJ
000856622 915__ $$0StatID:(DE-HGF)0111$$2StatID$$aWoS$$bScience Citation Index Expanded
000856622 915__ $$0StatID:(DE-HGF)0150$$2StatID$$aDBCoverage$$bWeb of Science Core Collection
000856622 915__ $$0StatID:(DE-HGF)9900$$2StatID$$aIF < 5
000856622 915__ $$0StatID:(DE-HGF)0510$$2StatID$$aOpenAccess
000856622 915__ $$0StatID:(DE-HGF)0030$$2StatID$$aPeer Review$$bDOAJ : Blind peer review
000856622 915__ $$0StatID:(DE-HGF)0310$$2StatID$$aDBCoverage$$bNCBI Molecular Biology Database
000856622 915__ $$0StatID:(DE-HGF)0300$$2StatID$$aDBCoverage$$bMedline
000856622 915__ $$0StatID:(DE-HGF)0320$$2StatID$$aDBCoverage$$bPubMed Central
000856622 915__ $$0StatID:(DE-HGF)0199$$2StatID$$aDBCoverage$$bClarivate Analytics Master Journal List
000856622 920__ $$lyes
000856622 9201_ $$0I:(DE-Juel1)ICS-4-20110106$$kICS-4$$lZelluläre Biophysik$$x0
000856622 9801_ $$aFullTexts
000856622 980__ $$ajournal
000856622 980__ $$aVDB
000856622 980__ $$aUNRESTRICTED
000856622 980__ $$aI:(DE-Juel1)ICS-4-20110106
000856622 981__ $$aI:(DE-Juel1)IBI-1-20200312